Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 25, 1998

View Archived Issues

Cambridge Antibody Suspends Trial Of Retinopathy Treatment

European Parliament Supports Streamlining Clinical Studies

Inex Blood-Cancer Drug Strong In Phase II Data

FGene Planning To Develop, License Out Existing Molecules

Phytopharm Raises £2.2M, Avoiding Discount Trend

Transatlantic Commerce Plan Aims To Speed Up Business

Scientists Formulating Plan Against Biological Attacks

Diagnostic Breast-Cancer Test To Focus On Estrogen Link

Prolifix Identifies Breast Cell Tumor-Creating Mechanism

Researchers Discover Medieval Secret To Safer Dye Coloring

Scotia Cuts Staff By Half, Focuses On Basic Research

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 26, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026